Skip to main content
Log in

Tissue-engineered heart valves predicted to be cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 euros

Reference

  • Huygens SA, et al. Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients. European Journal of Health Economics : 25 Jan 2020. Available from: URL: https://doi.org/10.1007/s10198-020-01159-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tissue-engineered heart valves predicted to be cost effective. PharmacoEcon Outcomes News 846, 27 (2020). https://doi.org/10.1007/s40274-020-6566-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6566-2

Navigation